Clinical Trial Result Information

Protocol number
ML21810

Title of Study
A Study of the Safety, Tolerability and Efficacy With Respect to the Maintenance of Hemoglobin Levels of Once Monthly Mircera in Dialysis Patients With Chronic Renal Anemia.

Sponsor
Hoffmann-la Roche

Company division
Pharmaceutical

Product name
Mircera

Generic name
methoxy polyethylene glycol-epoetin beta

Therapeutic area
Anemia

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
IV

Date of report
To be Published

Click here for the protocol registry listing of this trial.